Show Us the Money: Lessons in Transparency From State Pharmaceutical Marketing Disclosure Laws
Rozario, Natassia M
Rothman, David J
Health services research 2010 Feb ; 45(1): 98-114
OBJECTIVE: To assess legislation requiring drug companies to report gifts to providers, and to evaluate the information obtained. DATA SOURCES: Data included legislation in Vermont, Minnesota, Maine, Massachusetts, West Virginia, and the District of Columbia, and company disclosure data from Vermont. STUDY DESIGN: We evaluated the strengths and weaknesses of state legislation. We also analyzed 4 years of company disclosures from Vermont, assessing the value and distribution of industry-provider exchanges and identifying emerging trends in companies' practices. DATA COLLECTION METHODS: State legislation is publically available. We obtained Vermont's data through requests to the state's Attorney General's office. PRINCIPAL FINDINGS: Of the state laws, only Vermont's yielded robust, publically available data. These data show gifting was dominated by a few major corporations, and
Showing items related by title, author, creator and subject.
Chimonas, Susan; Frosch, Zachary; Rothman, David J (2011-01-10)It has become standard practice in medical journals to require authors to disclose their relationships with industry. However, these requirements vary among journals and often lack specificity. As a result, disclosures may ...
Health Industry Practices That Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers Brennan, Troyen A.; Rothman, David J.; Blank, Linda; Blumenthal, David; Chimonas, Susan C.; Cohen, Jordan J.; Goldman, Janlori; Kassirer, Jerome P.; Kimball, Harry; Naughton, James; Smelser, Neil (2006-01-25)Conflicts of interest between physicians' commitment to patient care and the desire of pharmaceutical companies and their representatives to sell their products pose challenges to the principles of medical professionalism. ...